Cell Expansion Market Analysis

The rising prevalence of chronic diseases coupled with increasing research activities for cell-based research is found to be the major factor driving the cell expansion market. Cardiovascular disease (CVD) is the leading cause of mortality worldwide. According to the WHO, an estimated 17.9 million people died from CVDs in 2016, representing 31% of all global deaths.

There is an increase in the prevalence of cancer patients that results in a large patient pool, which creates an opportunity for the manufacturers to tap and capitalize on the market. Hence there is an increase in the cases of chronic diseases that are expected to drive the overall market. Furthermore, technological advances in cell expansion devices and growth in government investments regarding healthcare issues are the factors propelling the market.  

Cell Expansion Industry Segments

As per the scope of the report, cell expansion deals with the production of daughter cells that arise from a single cell. This process is used in therapeutic development, drug screening, and microlevel research of cells. Presently, cell expansion is widely used to improve transplantation and in the treatment of various diseases such as rheumatoid arthritis, diabetes, and others. Cell expansion also ensures to simplify the overall task and to reduce labor-intensive manual tasks that are associated with the process.

Cell Expansion Market Trends

This section covers the major market trends shaping the Cell Expansion Market according to our research experts:

Consumables is Expected to be the Largest Growing Segment in the Cell Expansion Market

The consumables segment has been accounted for the largest share of the market and this is mainly due to the high demand during the production of regenerative medicine and rising research activities on stem cells in the biopharmaceutical companies. There is also a constant requirement for new reagents among end-users that helps in market growth. Furthermore, the rising awareness regarding advanced treatment therapies such as personalized medicine is also another driving factor for this segment.